These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34719210)

  • 1. Nanomaterials in Alzheimer's disease treatment: a comprehensive review.
    Faiyaz M; Ganayee MA; Akhtar S; Krishnan S; Flora B; Dogra D; Jha NK; Chellappan DK; Negi P; Dua K; Kesari KK; Gupta PK
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):851-865. PubMed ID: 34719210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of multifunctional nanomaterials in Alzheimer's disease: A potential theranostics strategy.
    Xu Y; Zhao M; Zhou D; Zheng T; Zhang H
    Biomed Pharmacother; 2021 May; 137():111360. PubMed ID: 33582451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegenerative Pathways in Alzheimer's Disease: A Review.
    Ramachandran AK; Das S; Joseph A; Shenoy GG; Alex AT; Mudgal J
    Curr Neuropharmacol; 2021; 19(5):679-692. PubMed ID: 32851951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
    Siafaka PI; Mutlu G; Okur NÜ
    Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease.
    Taliyan R; Kakoty V; Sarathlal KC; Kharavtekar SS; Karennanavar CR; Choudhary YK; Singhvi G; Riadi Y; Dubey SK; Kesharwani P
    J Control Release; 2022 Mar; 343():528-550. PubMed ID: 35114208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotherapeutic strategies for the treatment of Alzheimer's disease.
    Gu X; Chen H; Gao X
    Ther Deliv; 2015 Feb; 6(2):177-95. PubMed ID: 25690086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy.
    Xi Y; Chen Y; Jin Y; Han G; Song M; Song T; Shi Y; Tao L; Huang Z; Zhou J; Ding Y; Zhang H
    J Control Release; 2022 May; 345():38-61. PubMed ID: 35257810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in developing therapeutic strategies for Alzheimer's disease.
    Nguyen TT; Nguyen TTD; Nguyen TKO; Vo TK; Vo VG
    Biomed Pharmacother; 2021 Jul; 139():111623. PubMed ID: 33915504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology.
    Shabbir U; Rubab M; Tyagi A; Oh DH
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
    Roney C; Kulkarni P; Arora V; Antich P; Bonte F; Wu A; Mallikarjuana NN; Manohar S; Liang HF; Kulkarni AR; Sung HW; Sairam M; Aminabhavi TM
    J Control Release; 2005 Nov; 108(2-3):193-214. PubMed ID: 16246446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.
    Nguyen TT; Vo TK; Vo GV
    Adv Exp Med Biol; 2021; 1286():183-198. PubMed ID: 33725354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Nanomaterials in Neurodegenerative Diseases.
    Cui W; Fu W; Lin Y; Zhang T
    Curr Stem Cell Res Ther; 2021; 16(1):83-94. PubMed ID: 32213159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Nanotherapeutic Interventions for the Treatment of Alzheimer's Disease.
    Dogra A; Narang RS; Narang JK
    Curr Pharm Des; 2020; 26(19):2257-2279. PubMed ID: 32321393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.
    Trompetero A; Gordillo A; Del Pilar MC; Cristina VM; Bustos Cruz RH
    Curr Pharm Des; 2018; 24(1):22-45. PubMed ID: 28847307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies.
    Jha NK; Sharma A; Jha SK; Ojha S; Chellappan DK; Gupta G; Kesari KK; Bhardwaj S; Shukla SD; Tambuwala MM; Ruokolainen J; Dua K; Singh SK
    Open Biol; 2020 Dec; 10(12):200286. PubMed ID: 33352062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases.
    Marsool MDM; Prajjwal P; Reddy YB; Marsool ADM; Lam JR; Nandwana V
    Dis Mon; 2023 May; 69(5):101547. PubMed ID: 36931947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.